Supernus Pharmaceuticals, Inc.

SUPNNASDAQHealthcare● Active

$44.48

$-0.27(-0.60%)

Market Cap$2.6B

P/E Ratio—

52W High$59.68

52W Low$30.83

Avg Volume648K

Open$44.94

Beta0.54

Employees Ownership Insider Trades

Supernus Pharmaceuticals, Inc. (SUPN) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · SUPN · as of Mar 2, 2026

Latest filing snapshot

778

+104+15.43%vs prior year

Supernus Pharmaceuticals, Inc. (SUPN) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2025-12-31·Full-time · Global

Total Employees

778

Change (1Y)

+104

Growth % (1Y)

+15.43%

Revenue / Employee

$924.1K

Net Income / Employee

$-49.5K

Market Cap

$2.6B

SUPN Employee Count

2012 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2026-03-02	2025-12-31	778	+104	+15.43%
2025-02-25	2024-12-31	674	+22	+3.37%
2024-02-27	2023-12-31	652	+40	+6.54%
2023-03-09	2022-12-31	612	+37	+6.43%
2022-04-13	2021-12-31	575	+12	+2.13%
2021-03-08	2020-12-31	563	+99	+21.34%
2020-02-28	2019-12-31	464	+16	+3.57%
2019-03-01	2018-12-31	448	+26	+6.16%
2018-03-01	2017-12-31	422	+59	+16.25%
2017-03-16	2016-12-31	363	+19	+5.52%

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Drug Manufacturers - Specialty & Generic

#SymbolCompanyEmployeesMkt Cap

BHC

Bausch Health Companies Inc.

20,700$1.9B #2

AMRX

Amneal Pharmaceuticals, Inc.

8,300$4.4B #3

HCM

HUTCHMED (China) Limited

Supernus Pharmaceuticals, Inc.YOU

778$2.6B #6

CGON

CG Oncology, Inc. Common stock

113$4.8B #7

CNTA

Centessa Pharmaceuticals plc

77$6.1B

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · SUPN peer comparison

About SUPN employees

SUPN Employees · Headcount

Supernus Pharmaceuticals, Inc. (SUPN) employee data is sourced from the annual SEC 10-K filing. As of 2025, Supernus Pharmaceuticals, Inc. had 778 full-time employees globally. Full-time employees only. Global consolidated headcount.

Supernus Pharmaceuticals, Inc. employs 778 full-time employees as of the latest filing within the Drug Manufacturers - Specialty & Generic industry. Revenue per employee stands at $924,103, reflecting the company's operational efficiency.

Supernus Pharmaceuticals, Inc.'s workforce increased by 104 (15.43%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Supernus Pharmaceuticals, Inc.'s revenue per employee of $924,103 positions it among the notable performers in the Drug Manufacturers - Specialty & Generic sector for operational efficiency.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

SUPN Employees · 5 questions

As of the latest SEC 10-K filing (2025), Supernus Pharmaceuticals, Inc. had 778 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Supernus Pharmaceuticals, Inc. employee counthow many employees does Supernus Pharmaceuticals, Inc. haveSUPN total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-03-02